Outlook Therapeutics, Inc. (OTLK)
Nasdaq: OTLK · CIK 0001649989 · United States
Every official Outlook Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open OTLK filings
Outlook Therapeutics, Inc. documents
- Outlook Therapeutics, Inc. 10-K 2026OTLK 10-K 2026: annual report for fiscal 2026
- Outlook Therapeutics, Inc. 10-K 2025OTLK 10-K 2025: annual report for fiscal 2025
- Outlook Therapeutics, Inc. 10-K 2024OTLK 10-K 2024: annual report for fiscal 2024
- Outlook Therapeutics, Inc. 10-K 2023OTLK 10-K 2023: annual report for fiscal 2023
- Outlook Therapeutics, Inc. 10-K 2022OTLK 10-K 2022: annual report for fiscal 2022
- Outlook Therapeutics, Inc. 10-Q 2026OTLK 10-Q 2026: quarterly report for fiscal 2026
- Outlook Therapeutics, Inc. 10-Q 2025OTLK 10-Q 2025: quarterly report for fiscal 2025
- Outlook Therapeutics, Inc. 10-Q 2024OTLK 10-Q 2024: quarterly report for fiscal 2024
- Outlook Therapeutics, Inc. 10-Q 2023OTLK 10-Q 2023: quarterly report for fiscal 2023
- Outlook Therapeutics, Inc. 10-Q 2022OTLK 10-Q 2022: quarterly report for fiscal 2022
- Outlook Therapeutics, Inc. 8-K 2026OTLK 8-K 2026: current report for fiscal 2026
- Outlook Therapeutics, Inc. 8-K 2025OTLK 8-K 2025: current report for fiscal 2025
- Outlook Therapeutics, Inc. 8-K 2024OTLK 8-K 2024: current report for fiscal 2024
- Outlook Therapeutics, Inc. 8-K 2023OTLK 8-K 2023: current report for fiscal 2023
- Outlook Therapeutics, Inc. 8-K 2022OTLK 8-K 2022: current report for fiscal 2022
- Outlook Therapeutics, Inc. DEF 14A 2026OTLK DEF 14A 2026: proxy statement for fiscal 2026
- Outlook Therapeutics, Inc. DEF 14A 2025OTLK DEF 14A 2025: proxy statement for fiscal 2025
- Outlook Therapeutics, Inc. DEF 14A 2024OTLK DEF 14A 2024: proxy statement for fiscal 2024
- Outlook Therapeutics, Inc. DEF 14A 2023OTLK DEF 14A 2023: proxy statement for fiscal 2023
- Outlook Therapeutics, Inc. DEF 14A 2022OTLK DEF 14A 2022: proxy statement for fiscal 2022
- Outlook Therapeutics, Inc. Form 4 2026OTLK Form 4 2026: insider trading filing for fiscal 2026
- Outlook Therapeutics, Inc. Form 4 2025OTLK Form 4 2025: insider trading filing for fiscal 2025
- Outlook Therapeutics, Inc. Form 4 2024OTLK Form 4 2024: insider trading filing for fiscal 2024
- Outlook Therapeutics, Inc. Form 4 2023OTLK Form 4 2023: insider trading filing for fiscal 2023
- Outlook Therapeutics, Inc. Form 4 2022OTLK Form 4 2022: insider trading filing for fiscal 2022
- Outlook Therapeutics, Inc. S-1 2026OTLK S-1 2026: registration statement for fiscal 2026
- Outlook Therapeutics, Inc. S-1 2025OTLK S-1 2025: registration statement for fiscal 2025
- Outlook Therapeutics, Inc. S-1 2024OTLK S-1 2024: registration statement for fiscal 2024
- Outlook Therapeutics, Inc. S-1 2023OTLK S-1 2023: registration statement for fiscal 2023
- Outlook Therapeutics, Inc. S-1 2022OTLK S-1 2022: registration statement for fiscal 2022
- Outlook Therapeutics, Inc. 13F 2026OTLK 13F 2026: institutional holdings for fiscal 2026
- Outlook Therapeutics, Inc. 13F 2025OTLK 13F 2025: institutional holdings for fiscal 2025
- Outlook Therapeutics, Inc. 13F 2024OTLK 13F 2024: institutional holdings for fiscal 2024
- Outlook Therapeutics, Inc. 13F 2023OTLK 13F 2023: institutional holdings for fiscal 2023
- Outlook Therapeutics, Inc. 13F 2022OTLK 13F 2022: institutional holdings for fiscal 2022
More companies